• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Micell Technologies

edit

Micell Technologies, Inc., a biomedical device company, develops interventional cardiology systems for vascular drug delivery. It develops MiStent, a drug-eluting stent that allows control of drug release and pharmacokinetics. The company was founded in 1995 and is based in Raleigh, North Carolina.

Milestones

edit

• 
  Micell Technologies added Art Benvenuto as CEO.
  Posted 10/30/09 at 5:59pm
• 
  Micell Technologies received $7M in Unattributed funding. (7/12/07)
  Posted 3/15/10 at 11:12pm
• 
  Micell Technologies received $300k in Unattributed funding. (12/3/09)
  Posted 12/3/09 at 2:46pm via sec.gov
• 
  Micell Technologies received $15M in Series B funding. (10/1/09)
  Posted 10/30/09 at 5:59pm via onbiovc.com

Videos

Screenshots

edit

Above: Micell Technologies
Uploaded: 3/16/10

Sources

1. Cap Funding Report [edit]
2. Micell Technologies, Inc.: Series B $15M (onbiovc.com) [edit]
3. SEC (sec.gov) [edit]